Dermapharm Holding SE Logo

Dermapharm Holding SE

Manufactures patent-free branded pharmaceuticals & healthcare products for niche markets.

DMP | F

Overview

Corporate Details

ISIN(s):
DE000A2GS5D8
LEI:
5299009F0KNZINQQQK37
Country:
Germany
Address:
Lil-Dagover-Ring 7, 82031 Grünwald
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Dermapharm Holding SE is a manufacturer of patent-free branded pharmaceuticals and other healthcare products. Established in 1991, the company operates an integrated business model encompassing in-house research, development, production, and distribution. Its activities are primarily structured into two segments: "Branded pharmaceuticals and other healthcare products" and "Parallel import business." The company focuses on profitable, niche markets and implements a growth strategy that combines organic development with targeted acquisitions to expand its product portfolio and international footprint. Key assets include in-house R&D competence, a pipeline of development projects, and over 1,300 marketing authorizations for products such as over-the-counter medicines and herbal supplements.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-26 07:30
Earnings Release
Dermapharm confirms stable business development in H1 2025 and records EBITDA g…
English 25.4 KB
2025-08-26 00:00
Interim Report
Half-yearly financial report 2025
English 1.5 MB
2025-08-18 09:26
Report Publication Announcement
English 4.0 KB
2025-08-12 07:30
Earnings Release
Dermapharm Holding SE remains on projected growth trajectory in Q2 2025
English 15.1 KB
2025-07-04 16:18
Director's Dealing
Dermapharm Holding SE: Wilhelm Beier, buy
English 5.8 KB
2025-07-01 12:30
Declaration of Voting Results & Voting Rights Announcements
German 12.3 KB
2025-06-27 14:40
Declaration of Voting Results & Voting Rights Announcements
English 12.0 KB
2025-06-26 17:43
Post-Annual General Meeting Information
Dermapharm Holding SE: Annual General Meeting resolves dividend distribution of…
English 10.9 KB
2025-06-24 16:46
Director's Dealing
Dermapharm Holding SE: Dr. Andreas Eberhorn, buy
English 5.8 KB
2025-06-05 12:29
Director's Dealing
Dermapharm Holding SE: Anja Schorn, buy
English 6.2 KB
2025-06-04 11:19
Director's Dealing
Dermapharm Holding SE: Dr. Hans-Georg Feldmeier, buy
English 6.9 KB
2025-05-16 15:05
Pre-Annual General Meeting Information
Dermapharm Holding SE: Bekanntmachung der Einberufung zur Hauptversammlung am 2…
German 59.4 KB
2025-05-15 07:30
Earnings Release
Dermapharm Holding SE performs in line with projections in Q1 2025, confirms fu…
English 23.6 KB
2025-05-15 00:00
Interim Report
Q1 statement / Q1 financial report 2025
English 347.5 KB
2025-05-07 08:40
Report Publication Announcement
English 3.9 KB

Automate Your Workflow. Get a real-time feed of all Dermapharm Holding SE filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Dermapharm Holding SE via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2024-12-30 Themis Beteiligungs-Aktiengesellschaft Close relation Buy None 54,530,000.00 EUR
2024-12-30 Beier, Wilhelm Supervisory board Buy None 3,895,000.00 EUR
2024-11-15 Themis Beteiligungs-Aktiengesellschaft Close relation Buy None 6,464,000.00 EUR
2024-11-11 Feldmeier, Dr. Hans-Georg Board Buy None 95,185.00 EUR
2024-11-05 Dreibholz, Christof Board Buy None 27,720.00 EUR
2024-10-23 Lanz, Susanne Gertrud Pia Close relation Buy None 19,704.55 EUR
2024-08-29 Themis Beteiligungs-Aktiengesellschaft Close relation Buy None 29,954,600.00 EUR
2024-06-11 Lanz, Susanne Gertrud Pia Close relation Buy None 101,778.57 EUR
2024-05-22 Themis Beteiligungs-Aktiengesellschaft Close relation Buy None 8,577,500.00 EUR
2023-06-27 Feldmeier, Dr. Hans-Georg Board Buy None 99,902.36 EUR

Peer Companies

Company Country Ticker View
Aptahem AB Logo
Develops RNA aptamers to treat acute, life-threatening conditions like sepsis.
Sweden APTA
Aptamer Sciences Inc Logo
Develops aptamer-based therapeutics and diagnostics for oncology and solid tumors.
South Korea 291650
Arctic Bioscience Logo
Develops pharma & nutra ingredients from marine lipids for autoimmune & wellness applications.
Norway ABS
ArcticZymes Technologies Logo
Develops novel enzymes from Arctic organisms for diagnostics, therapeutics, and biopharma.
Norway AZT
ARECOR THERAPEUTICS PLC Logo
Biopharma firm enhancing drugs via reformulation for diabetes and pharmaceutical partners.
United Kingdom AREC
argenx SE Logo
Develops first-in-class antibody therapies for severe autoimmune diseases.
Netherlands 1AE
AroCell AB Logo
Develops and markets diagnostic tests for monitoring cancer and bacterial diseases.
Sweden AROC
Ascelia Pharma Logo
Develops novel drugs for rare oncology, including an oral MRI contrast agent for cancer patients.
Sweden ACE
Specializes in hormone drugs for OB/GYN, urology, internal medicine, and animal health.
Japan 4886
Astellas Pharma Inc. Logo
A global pharmaceutical company developing innovative medicines for unmet needs, focusing on oncology.
Japan 4503

Talk to a Data Expert

Have a question? We'll get back to you promptly.